1. TFPI from erythroblasts drives heme production in central macrophages promoting erythropoiesis in polycythemia.
- Author
-
Ma JK, Su LD, Feng LL, Li JL, Pan L, Danzeng Q, Li Y, Shang T, Zhan XL, Chen SY, Ying S, Hu JR, Chen XQ, Zhang Q, Liang T, and Lu XJ
- Subjects
- Humans, Animals, Mice, Janus Kinase 2 metabolism, Janus Kinase 2 genetics, Thrombomodulin metabolism, Thrombomodulin genetics, Mice, Knockout, Ferrochelatase metabolism, Ferrochelatase genetics, Male, MAP Kinase Signaling System, Mice, Inbred C57BL, Female, Polycythemia metabolism, Polycythemia genetics, Polycythemia pathology, Erythroblasts metabolism, Erythropoiesis, Heme metabolism, Lipoproteins metabolism, Macrophages metabolism, GATA1 Transcription Factor metabolism, GATA1 Transcription Factor genetics
- Abstract
Bleeding and thrombosis are known as common complications of polycythemia for a long time. However, the role of coagulation system in erythropoiesis is unclear. Here, we discover that an anticoagulant protein tissue factor pathway inhibitor (TFPI) plays an essential role in erythropoiesis via the control of heme biosynthesis in central macrophages. TFPI levels are elevated in erythroblasts of human erythroblastic islands with JAK2
V617F mutation and hypoxia condition. Erythroid lineage-specific knockout TFPI results in impaired erythropoiesis through decreasing ferrochelatase expression and heme biosynthesis in central macrophages. Mechanistically, the TFPI interacts with thrombomodulin to promote the downstream ERK1/2-GATA1 signaling pathway to induce heme biosynthesis in central macrophages. Furthermore, TFPI blockade impairs human erythropoiesis in vitro, and normalizes the erythroid compartment in mice with polycythemia. These results show that erythroblast-derived TFPI plays an important role in the regulation of erythropoiesis and reveal an interplay between erythroblasts and central macrophages., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF